Abstract Library

#3801 Local treatment of neuroendocrine liver metastases – How effective and safe is stereotactic microwave ablation?

Introduction: The less invasiveness of local ablation techniques such as stereotactic microwave ablation (SMWA) for the treatment of malignant hepatic lesions has made it an attractive alternative to conventional surgical resection.

Conference:

Presenting Author: Hanreich C

Authors: Hanreich C, Perrodin S, Candinas D, Lachenmayer A, Kim-Fuchs C,

Keywords: liver metastasis, microwave ablation, neuroendocrine tumor,

#3289 Short-interval, low-dose (SILD) Lu-177 DOTAiTATE therapy to overcome resistance to immunotherapy with PD-1 checkpoint inhibitors: Proof of concept to induce remission in patients with metastatic Merkel cell carcinoma and melanoma

Introduction: Immunotherapy with PD-1 immune checkpoint inhibitors (ICI) in Merkel cell carcinoma (MCC) or melanoma have proven efficacy.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Prasad V

Authors: Aicher A, Sindrilaru A, Beer A, Prasad V,

Keywords: PRRT, SILD, ICI, Merkel cell carcinoma, melanoma, tumor microenvironment remodelling,

#957 Outcome Predictors of Gastrinomas: The Role of ENETS Staging, Grading and Interdisciplinary Treatment

Introduction: Gastrinomas are rare neuroendocrine neoplasias (NEN) presenting with Zollinger‐Ellison‐syndrome (ZES).

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Felder S, Jann H, Tischer E, Pascher A, Denecke T,

Keywords: neuroendocrine, gastrinoma, zes, prognosis, therapy,

#839 Complete Mesenterial Venous Obstruction – A Clinical Syndrome Unique to Neuroendocrine Neoplasms of the Small Bowel

Introduction: Neuroendocrine neoplasms of the small bowel are mostly advanced or metastasized at diagnosis. Metastases typically occur in the mesenteric root and liver.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Petrovitch A, Hommann M, Kaemmerer D, Dreßler S, Trautvetter T,

Keywords: NET,

#397 Swiss Neuroendocrine Tumor (SwissNET) Registry: Update After Three Years

Introduction: To improve epidemiological data on patients with neuroendocrine tumors (NETs) in Switzerland, the Swiss registry for NETs (SwissNET) was established in 2008. Here we present the current state of the registry in 2011.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Stettler C, Limacher A, Christ E, Wagner S, Pralong F,

Keywords: neuroendocrine tumors, registries, carcinoid tumor,